Investor Relations


Zogenix, Inc. (Nasdaq: ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
NASDAQ | ZGNX (Common Stock)
$10.80 + 0.20
Stock chart for: ZGNX.O.  Currently trading at $10.80 with a 52 week high of $13.70 and a 52 week low of $7.33.
Data as of 04/25/17 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Latest Presentations

Zogenix April 2017 Investor Presentation
Download Documentation

Recent News More

Zogenix to Participate in the Oppenheimer 27th Annual Healthcare Conference

Read More

Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results

Read More

Investor Events More

Thursday, March 9, 2017 4:30 p.m. ET
Q4 2016 Zogenix, Inc. Earnings Conference Call